| Literature DB >> 35365191 |
Émilie Bouchard1,2, Rajnish Sharma3, Adrián Hernández-Ortiz3, Kayla Buhler3, Batol Al-Adhami4, Chunlei Su5, Heather Fenton6, Géraldine G-Gouin7, James D Roth8, Chloé Warret Rodrigues8, Carla Pamak9, Audrey Simon10, Nicholas Bachand3, Patrick Leighton10, Emily Jenkins3.
Abstract
BACKGROUND: In changing northern ecosystems, understanding the mechanisms of transmission of zoonotic pathogens, including the coccidian parasite Toxoplasma gondii, is essential to protect the health of vulnerable animals and humans. As high-level predators and scavengers, foxes represent a potentially sensitive indicator of the circulation of T. gondii in environments where humans co-exist. The objectives of our research were to compare serological and molecular assays to detect T. gondii, generate baseline data on T. gondii antibody and tissue prevalence in foxes in northern Canada, and compare regional seroprevalence in foxes with that in people from recently published surveys across northern Canada.Entities:
Keywords: Canada; ELISA; Foxes; MC-qPCR; Sentinel species; Toxoplasma gondii
Mesh:
Substances:
Year: 2022 PMID: 35365191 PMCID: PMC8972674 DOI: 10.1186/s13071-022-05229-3
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Prevalence of T. gondii and locations of foxes (Vulpes vulpes/V. lagopus, n = 749) harvested by local trappers in Canada: ISR (NT), Cambridge Bay (NU), Churchill (MB), Nunavik (QC), James Bay (QC), Côte-Nord (QC), Southern QC, Nunatsiavut (NL), Western Labrador (NL), and Central Labrador (NL). The asterisk (*) indicates that both Vulpes species were combined due to high number of unknowns
Prevalence and risk factors in foxes (Vulpes spp; n = 749) harvested from Canada
| Seroprevalencea (CI95%)/ | Tissue prevalence (CI95%)/ | ||
|---|---|---|---|
| Species | Red fox | 41% (36–45)/530 | 30% (26–34)/548 |
| Arctic fox | 21% (16–28)/169 | 20% (15–27)/171 | |
| Unknown species | 31% (17–49)/29 | 23% (12–41)/30 | |
| Sex | Male | 36% (32–41)/387 | 27% (23–32)/397 |
| Female | 31% (26–37)/293 | 25% (20–30)/302 | |
| Unknown sex | 60% (46–73)/48 | 44% (31–58)/50 | |
| Age | Young (≤ 1 year old) | 22% (18–27)/370 | 19% (16–24)/383 |
| Mature (2–4 year old) | 37% (30–44)/180 | 24% (18–30)/187 | |
| Older (≥ 5 year old) | 64% (52–74)/66 | 45% (34–57)/66 | |
| Unknown age | 62% (52–70)/112 | 50% (41–59)/113 | |
| Region | Northern Labrador, NL | 34% (21–50)/38 | 24% (13–39)/38 |
| Central Labrador, NL | 38% (18–61)/16 | 38% (21–57)/24 | |
| Western Labrador, NL | 38% (25–52)/48 | 21% (12–34)/48 | |
| Ungava Bay, QC | 29% (22–36)/154 | 19% (14–25)/165 | |
| Eastern Hudson Bay, QC | 65% (54–75)/74 | 51% (40–62)/75 | |
| Côte-Nord, QC | 31% (21–43)/64 | 23% (15–35)/65 | |
| James Bay, QC | 31% (22–41)/91 | 26% (18–36)/91 | |
| Southern QC | 65% (55–74)/89 | 52% (41–62)/89 | |
| Churchill, MB | 24% (13–39)/42 | 19% (10–33)/42 | |
| Cambridge Bay, NU | 20% (11–35)/40 | 18% (9–32)/40 | |
| Ulukhaktok, NT | 10% (5–19)/72 | 11% (6–20)/72 | |
| BCI | 1 (no to very little fat) | 32% (26–38)/250 | 25% (20–30)/256 |
| 2 (moderate fat) | 28% (23–34)/293 | 21% (16–25)/297 | |
| 3 (abundant fat) | 42% (32–52)/91 | 30% (22–40)/92 | |
| Unknown BCI | 64% (54–73)/94 | 51% (41–60)/104 | |
| Total | 36% (32–39)/728 | 27% (24–31)/749 |
N number of individuals tested, CI confidence intervals, BCI body condition index
aIndividuals not tested (no heart fluid) = 21
Comparison of Toxoplasma gondii results for heart fluid samples using serological methods (ELISA and IFAT) relative to magnetic capture real-time PCR to determine the best dilution for cutoff values
| Dilutions | ID | ELISA S/P% | IFAT | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ND | 1:2 | 1:4 | 1:8 | 1:2 | 1:10 | 1:50 | 1:100 | ||
| N | BJ2016-223 | 27.31 | 13.84 | 13.3 | 11.56 | 1 + | N | N | N |
| W2015-221 | 13.3 | 2.33 | 1.68 | 1.19 | N | N | N | N | |
| Mi2015-214 | 21.34 | 2.99 | 1.47 | 1.36 | N | N | N | N | |
| LP | We2015-248 | 243.81 | 237.62 | 227.31 | 195.87 | 3 + | 3 + | 2 + | 1 + |
| We2015-253 | 344.84 | 325.35 | 296.58 | 281.05 | 3 + | 3 + | 2 + | 2 + | |
| W2015-218 | 17.92 | 8.31 | 6.13 | 2.5 | 1 + | N | N | N | |
| HP | We2015-250 | 351.79 | 332.19 | 323.13 | 295.77 | 3 + | 3 + | 3 + | 3 + |
| W2015-227 | 297.94 | 272.58 | 239.47 | 203.53 | 3 + | 3 + | 2 + | 1 + | |
| FN21 | 331.65 | 309.55 | 291.8 | 244.46 | 3 + | 3 + | 2 + | 2 + | |
Positive results: ELISA ≥ 70% and IFAT ≥ 1 +
N negative, LP low positive on magnetic capture (Cp value > 30), HP high positive on magnetic capture (Cp value ≤ 30), ND no dilution, ELISA enzyme-linked immunosorbent assay, IFAT indirect fluorescent antibody test
Coefficients of the final logisitic regression model and risk factors associated to Toxoplasma gondii serological and tissue prevalence in foxes (Vulpes spp.) in Canada
| Variables | β (SE) | OR (CI95%) | ||
|---|---|---|---|---|
| Variables for seroprevalence | ||||
| Species, red fox | 0.42 (0.50) | 0.404 | 1 | 1.52 (0.59–4.28) |
| Sex, male | 0.97 (0.46) | 0.036* | 1 | 2.65 (1.11–6.92) |
| Age, mature | 0.69 (0.21) | 0.001* | 2 | 1.99 (1.31–3.02) |
| Age, old | 1.93 (0.32) | < 0.001* | 2 | 6.86 (3.74–12.96) |
| Latitude | − 0.07 (0.02) | < 0.001* | 1 | 0.93 (0.88–0.98) |
| BCI, low | − 0.60 (0.30) | 0.042* | 2 | 0.55 (0.31–0.98) |
| BCI, medium | − 0.66 (0.29) | 0.024* | 2 | 0.52 (0.29–0.92) |
| Species^sex, male red fox | − 0.73 (0.51) | 0.156 | 1 | 0.48 (0.17–1.29) |
| Variables for tissue prevalence | ||||
| Species, red fox | 0.14 (0.59) | 0.807 | 1 | 1.15 (0.39–4.02) |
| Sex, male | 1.48 (0.53) | 0.005* | 1 | 4.39 (1.66–13.88) |
| Age, mature | 0.36 (0.24) | 0.137 | 2 | 1.43 (0.89–2.29) |
| Age, old | 1.13 (0.33) | < 0.001* | 2 | 3.10 (1.62–5.86) |
| Latitude | − 0.08 (0.03) | 0.003* | 1 | 0.92 (0.87–0.97) |
| BCI, low | − 0.48 (0.32) | 0.139 | 2 | 0.62 (0.33–1.18) |
| BCI, medium | − 0.66 (0.33) | 0.044* | 2 | 0.52 (0.28–0.99) |
| Species^sex, male red fox | − 1.19 (0.59) | 0.042* | 1 | 0.30 (0.09–0.91) |
BCI body condition index, SpeciesSex interaction term, β estimate coefficient, SE standard error, df degree of freedom, OR odds ratio, CI 95% confidence interval
*Statistically significant at p < 0.05
Fig. 2Exposure of T. gondii in people and foxes harvested in Inuvialuit (NT), Nunavut (NU), Nunavik (QC), Nunatsiavut (NL), and James Bay (QC), Canada. Red dots indicate northern communities. Results from both fox species were combined. Credit map: Statistics Canada
Infection intensity (tachyzoites equivalent per gram) of Toxoplasma gondii in foxes (Vulpes spp.) in Canada
| Variables | Category ( | Mean TEG (CI95%); SE |
|---|---|---|
| Species | Arctic foxes (30) | 27,117.46 (5939.70–48,295.21); 10,354.71 |
| Red foxes (137) | 5315.85 (1824.39–8807.31); 1765.54 | |
| Age | Young (67) | 13,137.21 (2938.79–23,335.84); 5108.04 |
| Mature (40) | 6755.22 (− 817.35–14,327.79); 3743.81 | |
| Old age (24) | 4154.19 (− 2916.23–11,224.62); 3417.88 | |
| Sex | Male (98) | 11,210.20 (3794.33–18,626.07); 3736.48 |
| Female (58) | 6319.44 (576.25–12,062.62); 2868.06 | |
| BCI | High (24) | 5609.90 (− 3793.16–15,012.96); 4545.49 |
| Medium (51) | 15,687.50 (3030.87–28,344.14); 6301.34 | |
| Low (56) | 5632.37 (− 596.50–11,861.25); 3108.15 |
BCI body condition index, N number of foxes in the respective category for which TEG was estimated (TEG was not estimated for all positive tissues on MC-qPCR because of lack of data, e.g. missing heart or brain), TEG tachyzoite equivalents per gram, CI 95% confidence interval, SE standard error
Coefficients of the generalized linear model and potential risk factors for infection intensity (tachyzoites equivalent per gram of tissues; log transformed) of Toxoplasma gondii in foxes (Vulpes spp.) in Canada
| Variables | β (SE) | 95% Wald confidence interval | Hypothesis test | |||
|---|---|---|---|---|---|---|
| Lower | Upper | Wald-chi-Square | ||||
| First model | ||||||
| Species, Arctic fox | 0.228 (0.3744) | − 0.506 | 0.962 | 0.371 | 1 | 0.542 |
| Sex, male | 0.209 (0.2568) | − 0.294 | 0.713 | 0.664 | 1 | 0.415 |
| BCI, low | 0.113 (0.3259) | − 0.526 | 0.751 | 0.119 | 1 | 0.730 |
| BCI, medium | 0.581 (0.3327) | − 0.071 | 1.233 | 3.046 | 1 | 0.081 |
| Latitude | 0.020 (0.0302) | − 0.039 | 0.079 | 0.448 | 1 | 0.503 |
| Age, young | 0.384 (0.3200) | − 0.244 | 1.011 | 1.438 | 1 | 0.231 |
| Age, mature | 0.320 (0.3377) | − 0.342 | 0.982 | 0.898 | 1 | 0.343 |
| Final model | ||||||
| BCI | 0.033 (0.0212) | − 0.008 | 0.075 | 2.478 | 1 | 0.115 |
| BCI | 0.042 (0.0207) | 0.002 | 0.083 | 4.152 | 1 | 0.042* |
| BCI | 0.030 (0.0216) | − 0.013 | 0.072 | 1.895 | 1 | 0.169 |
BCI body condition index, β estimate coefficient, SE standard error, df degree of freedom, BCIlat interaction term
*Statistically significant at p < 0.05